naftopidil and Androgen-Independent Prostatic Cancer

naftopidil has been researched along with Androgen-Independent Prostatic Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arima, K; Ishii, K; Kajiwara, S; Kanda, H; Kato, M; Matsuoka, I; Miki, M; Sasaki, T; Shiraishi, T; Sugimura, Y	1

Other Studies

1 other study(ies) available for naftopidil and Androgen-Independent Prostatic Cancer

Article	Year
Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells. Journal of cancer research and clinical oncology, 2018, Volume: 144, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Docetaxel; Drug Synergism; Humans; Male; Mice; Mice, Nude; Naphthalenes; Piperazines; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Random Allocation; Taxoids; Xenograft Model Antitumor Assays	2018

Article

Year

Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells.

Journal of cancer research and clinical oncology, 2018, Volume: 144, Issue:1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Docetaxel; Drug Synergism; Humans; Male; Mice; Mice, Nude; Naphthalenes; Piperazines; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Random Allocation; Taxoids; Xenograft Model Antitumor Assays

2018